DMAAR (STOCKS)

    Drugs Made In America Acquisition Corp. Rights

    Change: —
    Prev close: —
    Company Information
    Exchange
    XNAS
    Sector
    Industry
    CEO
    Asset Type
    stocks
    Website
    Fundamentals
    Market Cap
    Employees
    P/E (TTM)
    P/B (TTM)
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Nonoperating Income/Loss $9.28M
    Operating Income/Loss -$2.63M
    Income/Loss From Continuing Operations After Tax $6.66M
    Income/Loss From Continuing Operations Before Tax $6.66M
    Net Income/Loss $6.66M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent $6.66M
    Net Income/Loss Available To Common Stockholders, Basic $6.66M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Assets $242.04M
    Current Assets $14.89K
    Noncurrent Assets $242.02M
    Liabilities $7.39M
    Current Liabilities $492.17K
    Noncurrent Liabilities $6.90M
    Equity -$7.38M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent -$7.38M
    Temporary Equity $242.02M
    Temporary Equity Attributable To Parent $242.02M
    Liabilities And Equity $242.04M
    Net Cash Flow From Operating Activities -$379.19K
    Net Cash Flow From Operating Activities, Continuing -$379.19K
    Net Cash Flow From Investing Activities -$8.75K
    Net Cash Flow From Investing Activities, Continuing -$9.18K
    Net Cash Flow From Financing Activities $393.16K
    Net Cash Flow From Financing Activities, Continuing $393.16K
    Net Cash Flow $4.79K
    Net Cash Flow, Continuing $4.79K
    Comprehensive Income/Loss $6.66M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent $6.66M
    Other Comprehensive Income/Loss $0.00